AstraZeneca plc Company Profile (LON:AZN)

About AstraZeneca plc (LON:AZN)

AstraZeneca plc logoAstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVMD, it is expanding its portfolio into the cardiovascular-renal area with late-stage assets, such as ZS-9 and roxadustat, as well as investing to explore the benefits of its SGLT2 and GLP-1 franchises in chronic kidney disease (CKD) and heart failure (HF). The Company has approximately 40 projects in Phase I, including 29 new molecular entities (NMEs), and 11 oncology combination projects. It has approximately 40 projects in Phase II, including 25 NMEs; four significant additional indications for projects that have reached phase II, and seven oncology combination projects.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Pharmaceuticals - NEC
  • Sub-Industry: N/A
  • Symbol: LON:AZN
  • CUSIP: N/A
  • Web: www.astrazeneca.com/
Capitalization:
  • Market Cap: £56.91 billion
  • Outstanding Shares: 1,266,000,000
Average Prices:
  • 50 Day Moving Avg: GBX 4,761.27
  • 200 Day Moving Avg: GBX 4,875.67
  • 52 Week Range: GBX 3,996 - GBX 5,520
P/E:
  • Trailing P/E Ratio: 14.74
  • P/E Growth: 3.37
Sales & Book Value:
  • Annual Revenue: £21.74 billion
  • Price / Sales: 2.62
  • Book Value: GBX 10.78 per share
  • Price / Book: 4.17
Dividend:
  • Dividend Yield: 5.0%
Profitability:
  • EBIDTA: £5.91 billion
  • Net Margins: 8.83%
  • Return on Equity: 14.36%
  • Return on Assets: 2.84%
Misc:
  • Average Volume: 2.12 million shs.
 

Frequently Asked Questions for AstraZeneca plc (LON:AZN)

What is AstraZeneca plc's stock symbol?

AstraZeneca plc trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

How often does AstraZeneca plc pay dividends? What is the dividend yield for AstraZeneca plc?

AstraZeneca plc announced a dividend on Thursday, July 27th. Stockholders of record on Thursday, August 10th will be paid a dividend of GBX 68.90 per share on Monday, September 11th. This represents a dividend yield of 1.35%. The ex-dividend date of this dividend is Thursday, August 10th. The official announcement can be accessed at this link. View AstraZeneca plc's Dividend History.

Where is AstraZeneca plc's stock going? Where will AstraZeneca plc's stock price be in 2017?

20 equities research analysts have issued 1-year price objectives for AstraZeneca plc's stock. Their forecasts range from GBX 3,900 to GBX 6,500. On average, they anticipate AstraZeneca plc's stock price to reach GBX 4,914.75 in the next twelve months. View Analyst Ratings for AstraZeneca plc.

Who are some of AstraZeneca plc's key competitors?

Who are AstraZeneca plc's key executives?

AstraZeneca plc's management team includes the folowing people:

  • Pascal Soriot, Executive Director and Chief Executive Officer
  • Marc Dunoyer, Executive Director, Chief Financial Officer
  • Fiona Cicconi, Executive Vice-President, Human Resources
  • Sean Bohen M.D., Ph.D., Chief Medical Officer, Executive Vice President - Global Medicines Development
  • Pam P. Cheng, Executive Vice President - Operations and Information Technology
  • Ruud Dobber, Executive Vice President, North America
  • Bahija Jallal Ph.D., Executive Vice President, MedImmune
  • Mark Mallon, Executive Vice President, Global Product and Portfolio Strategy, Global Medical Affairs & Corporate Affairs Executive Vice-President, International West
  • Menelas Pangalos, Executive Vice President - IMED Biotech Unit and Global Business Development
  • Leon Wang, Executive Vice President - Asia Pacific

How do I buy AstraZeneca plc stock?

Shares of AstraZeneca plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is AstraZeneca plc's stock price today?

One share of AstraZeneca plc stock can currently be purchased for approximately GBX 4,495.


MarketBeat Community Rating for AstraZeneca plc (LON AZN)
Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  850 (Vote Outperform)
Underperform Votes:  1,190 (Vote Underperform)
Total Votes:  2,040
MarketBeat's community ratings are surveys of what our community members think about AstraZeneca plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for AstraZeneca plc (LON:AZN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Sell Ratings, 8 Hold Ratings, 9 Buy Ratings
Consensus Rating:Hold (Score: 2.30)
Consensus Price Target: GBX 4,914.75

Analysts' Ratings History for AstraZeneca plc (LON:AZN)
Show:
DateFirmActionRatingPrice TargetDetails
8/24/2017Jefferies Group LLCDowngradeHoldGBX 4,400 -> GBX 4,359View Rating Details
8/21/2017Liberum CapitalReiterated RatingBuyGBX 4,800View Rating Details
8/18/2017Shore CapitalReiterated RatingHoldView Rating Details
8/18/2017Goldman Sachs Group, Inc. (The)Set Price TargetSellGBX 3,900View Rating Details
8/9/2017J P Morgan Chase & CoSet Price TargetNeutralGBX 4,200View Rating Details
8/9/2017InvestecUpgradeHold -> BuyGBX 5,000 -> GBX 4,900View Rating Details
8/8/2017HSBC Holdings plcSet Price TargetSellGBX 4,100View Rating Details
8/7/2017Barclays PLCReiterated RatingOverweightGBX 5,500View Rating Details
8/3/2017Deutsche Bank AGLower Price TargetBuyGBX 5,700 -> GBX 5,300View Rating Details
7/28/2017Morgan StanleyDowngradeEqual WeightGBX 5,600 -> GBX 4,700View Rating Details
7/28/2017Beaufort SecuritiesDowngradeSellGBX 3,900View Rating Details
7/28/2017Kepler Capital MarketsSet Price TargetBuyGBX 5,200View Rating Details
7/28/2017Citigroup Inc.Reiterated RatingBuyGBX 6,000View Rating Details
7/28/2017Berenberg BankSet Price TargetBuyGBX 5,500View Rating Details
7/28/2017Credit Suisse GroupLower Price TargetNeutralGBX 5,000 -> GBX 4,700View Rating Details
7/27/2017S&P GlobalSet Price TargetNeutralGBX 4,500View Rating Details
7/21/2017BNP ParibasReiterated RatingNeutralView Rating Details
4/28/2017Sanford C. BernsteinSet Price TargetNeutralGBX 4,736View Rating Details
3/23/2017Societe GeneraleReiterated RatingBuyView Rating Details
2/28/2017Bryan, Garnier & CoReiterated RatingBuyGBX 5,400View Rating Details
6/24/2016Independent Research GmbHSet Price TargetSellGBX 3,650View Rating Details
5/10/2016Oddo SecuritiesReiterated RatingBuyGBX 5,400View Rating Details
5/5/2016Charles StanleyUpgradeStrong-BuyView Rating Details
3/24/2016NatixisReiterated RatingNeutralGBX 4,456View Rating Details
3/23/2016NomuraLower Price TargetHoldGBX 4,880 -> GBX 4,350View Rating Details
2/12/2016Baader BankReiterated RatingHoldGBX 4,400View Rating Details
2/9/2016AlphaValueUpgradeBuyGBX 4,640View Rating Details
2/4/2016S&P Equity ResearchSet Price TargetNeutralGBX 4,500View Rating Details
2/2/2016HandelsbankenReiterated RatingAccumulateGBX 5,220.30View Rating Details
1/28/2016Pareto SecuritiesReiterated RatingSellGBX 3,855.35View Rating Details
1/27/2016SwedbankReiterated RatingBuyGBX 5,115.47View Rating Details
1/13/2016Nordea Equity ResearchReiterated RatingHoldGBX 4,698.35View Rating Details
(Data available from 8/24/2015 forward)

Earnings

Earnings History for AstraZeneca plc (LON:AZN)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for AstraZeneca plc (LON:AZN)
Current Year EPS Consensus Estimate: $3.76 EPS

Dividends

Dividend History by Quarter for AstraZeneca plc (LON AZN)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/27/2017GBX 68.901.35%8/10/20178/10/20179/11/2017
2/2/2017GBX 150.203.52%2/16/20172/16/20173/20/2017
7/28/2016GBX 68.701.37%8/11/20168/11/20169/12/2016
2/4/2016GBX 1313.16%2/18/20162/18/20163/21/2016
7/30/2015GBX 57.501.33%8/13/20158/13/20159/14/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for AstraZeneca plc (LON:AZN)
Insider Trades by Quarter for AstraZeneca plc (LON:AZN)
Insider Trades by Quarter for AstraZeneca plc (LON:AZN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/27/2017Nazneen RahmanInsiderBuy39GBX 4,370£1,704.30
10/27/2015Courtois,Jean-PhilippeInsiderBuy900GBX 4,423£39,807
8/28/2015Soriot,PascalInsiderBuy76,300GBX 3,960£3,021,480
5/7/2015Marc DunoyerInsiderBuy10,000GBX 4,397£439,700
4/30/2015Ann CairnsInsiderBuy1,100GBX 4,455£49,005
4/29/2015Shriti VaderaInsiderBuy3,500GBX 4,563£159,705
4/28/2015Graham ChipchaseInsiderBuy1,100GBX 4,606£50,666
4/27/2015Bruce BurlingtonInsiderBuy600GBX 4,662£27,972
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for AstraZeneca plc (LON:AZN)
Latest Headlines for AstraZeneca plc (LON:AZN)
Source:
DateHeadline
americanbankingnews.com logoAstraZeneca plc's (AZN) Buy Rating Reaffirmed at Liberum Capital
www.americanbankingnews.com - August 21 at 7:14 PM
americanbankingnews.com logoAstraZeneca plc (AZN) Earns "Hold" Rating from Shore Capital
www.americanbankingnews.com - August 20 at 12:50 AM
americanbankingnews.com logoGoldman Sachs Group, Inc. (The) Analysts Give AstraZeneca plc (AZN) a GBX 3,900 Price Target
www.americanbankingnews.com - August 20 at 12:50 AM
nasdaq.com logoFDA Nod For PFE, New Use For AZN's Ovarian Cancer Drug, ELGX's LEOPARD Hits Goal - Nasdaq
www.nasdaq.com - August 18 at 3:44 AM
reuters.com logoBRIEF-Astrazeneca says non-exec director Burlington to retire
www.reuters.com - August 16 at 3:19 AM
americanbankingnews.com logoAstraZeneca plc (AZN) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - August 15 at 6:50 AM
finance.yahoo.com logoEdited Transcript of AZN.L earnings conference call or presentation 27-Jul-17 12:30pm GMT
finance.yahoo.com - August 13 at 3:55 PM
finance.yahoo.com logoBrexit Is Quietly Killing Science
finance.yahoo.com - August 8 at 1:36 AM
nasdaq.com logoEx-Dividend Reminder: Wal-Mart Stores, Nexstar Media Group and AstraZeneca - Nasdaq
www.nasdaq.com - August 7 at 3:24 PM
fool.com logo3 High-Yield Stocks for Aggressive Investors
www.fool.com - August 7 at 2:26 PM
finance.yahoo.com logoAstraZeneca Takes a Long Shot on Lung Cancer Drug Study
finance.yahoo.com - August 7 at 1:54 AM
fool.com logoAstraZeneca plc: Buy the Dip? - Motley Fool
www.fool.com - August 4 at 4:40 PM
fool.com logoWhy AstraZeneca plc Stock Broke Down in July - Motley Fool
www.fool.com - August 4 at 4:40 PM
fool.com logoWhy AstraZeneca plc Stock Broke Down in July
www.fool.com - August 4 at 10:51 AM
fool.com logoAstraZeneca plc: Buy the Dip?
www.fool.com - August 3 at 8:22 PM
seekingalpha.com logoAstraZeneca Stages Major Lung Cancer Comeback - Seeking Alpha
seekingalpha.com - August 3 at 3:05 AM
seekingalpha.com logoAstraZeneca Gets The Bad News - Seeking Alpha
seekingalpha.com - August 2 at 10:03 PM
finance.yahoo.com logoAstraZeneca Plc :AZN-GB: Earnings Analysis: Q2, 2017 By the Numbers : August 2, 2017
finance.yahoo.com - August 1 at 11:24 PM
nasdaq.com logoPre-Market Most Active for Jul 31, 2017 : SNI, DISCA, SNAP, BTI, RATE, DISCK, AZN, X, FEYE, UMC, TVIX, USLV - Nasdaq
www.nasdaq.com - July 31 at 4:25 PM
marketwatch.com logoAstraZeneca's Imfinzi gets sped-up FDA process - MarketWatch
www.marketwatch.com - July 31 at 4:25 PM
americanbankingnews.com logoAstraZeneca plc (AZN) Given a GBX 5,500 Price Target at Berenberg Bank
www.americanbankingnews.com - July 30 at 6:35 PM
americanbankingnews.com logoAstraZeneca plc's (AZN) Buy Rating Reiterated at Citigroup Inc.
www.americanbankingnews.com - July 30 at 2:08 PM
americanbankingnews.com logoKepler Capital Markets Analysts Give AstraZeneca plc (AZN) a GBX 5,200 Price Target
www.americanbankingnews.com - July 30 at 12:50 PM
americanbankingnews.com logoAstraZeneca plc (AZN) PT Lowered to GBX 4,200
www.americanbankingnews.com - July 30 at 12:15 PM
americanbankingnews.com logoBeaufort Securities Lowers AstraZeneca plc (AZN) to Sell
www.americanbankingnews.com - July 29 at 11:17 PM
americanbankingnews.com logoMorgan Stanley Downgrades AstraZeneca plc (LON:AZN) to Equal Weight
www.americanbankingnews.com - July 29 at 10:34 PM
seekingalpha.com logoAstraZeneca: Will Pfizer Come Knocking Again? - Seeking Alpha
seekingalpha.com - July 29 at 3:57 PM
finance.yahoo.com logoWhat's Next for AstraZeneca and Its Dividend?
finance.yahoo.com - July 29 at 3:57 PM
nasdaq.com logoMoody's takes negative outlook on AstraZeneca's debt - Nasdaq
www.nasdaq.com - July 28 at 5:35 PM
finance.yahoo.com logoAstraZeneca (AZN) Beats on Q2 Earnings, Falls on Failed Study
finance.yahoo.com - July 28 at 5:35 PM
finance.yahoo.com logo[$$] AstraZeneca climbs after cancer drug reassessment
finance.yahoo.com - July 28 at 5:35 PM
finance.yahoo.com logoZeneca Wilmington Inc. -- Moody's changes outlook on AstraZenaca's A3 rating to negative; affirms ratings
finance.yahoo.com - July 28 at 5:35 PM
finance.yahoo.com logoMoody's takes negative outlook on AstraZeneca's debt
finance.yahoo.com - July 28 at 5:35 PM
americanbankingnews.com logoAstraZeneca plc (AZN) Insider Buys £1,704.30 in Stock
www.americanbankingnews.com - July 28 at 10:39 AM
seekingalpha.com logoAstraZeneca Plc's (AZN) CEO Pascal Soriot on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - July 27 at 9:47 PM
finance.yahoo.com logo[$$] AstraZeneca Shocker Reminds Investors Miracle Drugs Are No Remedy for Risk
finance.yahoo.com - July 27 at 9:47 PM
finance.yahoo.com logo[$$] AstraZeneca Faces Major Setback Over Cancer Drugs
finance.yahoo.com - July 27 at 9:47 PM
finance.yahoo.com logoMighty AstraZeneca Takes a Lickin' on Failed Mystic Trial
finance.yahoo.com - July 27 at 9:47 PM
americanbankingnews.com logoAstraZeneca plc (AZN) Given a GBX 4,500 Price Target by S&P Global Analysts
www.americanbankingnews.com - July 27 at 4:05 PM
investorplace.com logoAstraZeneca plc (ADR) (AZN) Stock Tanks on Lung Cancer Drug Disappointment
investorplace.com - July 27 at 12:10 PM
americanbankingnews.com logoAstraZeneca plc to Issue Dividend of GBX 68.90 (AZN)
www.americanbankingnews.com - July 27 at 11:16 AM
feeds.benzinga.com logoWhy Is AstraZeneca Sinking Today?
feeds.benzinga.com - July 27 at 10:20 AM
americanbankingnews.com logoAstraZeneca plc (AZN) Given a GBX 5,150 Price Target at UBS AG
www.americanbankingnews.com - July 27 at 6:20 AM
finance.yahoo.com logoIs Lower Revenue in the Cards for AstraZeneca’s 2Q17?
finance.yahoo.com - July 26 at 9:59 PM
morningstar.co.uk logoAstraZeneca Receives EU Approval For Faslodex Breast Cancer Drug
www.morningstar.co.uk - July 26 at 4:57 PM
americanbankingnews.com logoAstraZeneca plc (AZN) Rating Reiterated by J P Morgan Chase & Co
www.americanbankingnews.com - July 22 at 12:18 PM
americanbankingnews.com logoAstraZeneca plc (LON:AZN) Receives "Neutral" Rating from BNP Paribas
www.americanbankingnews.com - July 21 at 8:16 AM
americanbankingnews.com logoAstraZeneca plc (AZN) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - July 21 at 7:36 AM
seekingalpha.com logoChaos At AstraZeneca - Seeking Alpha
seekingalpha.com - July 19 at 10:33 PM
americanbankingnews.com logoAstraZeneca plc (LON:AZN) to Release Earnings on Wednesday
www.americanbankingnews.com - July 19 at 2:58 AM

Social

Social activity is not available for this stock.

Chart

AstraZeneca plc (AZN) Chart for Thursday, August, 24, 2017

This page was last updated on 8/24/2017 by MarketBeat.com Staff